Rocket Pharmaceuticals in-27RCKTWPreferred / convertible
13F holders, Q4 2025 (December 31)12holders +1
3new positions
2sold out
1famous investor
$0.10avg. 13F price*
At the end of Q4 2025, 12 institutions reported holding Rocket Pharmaceuticals in-27 (RCKTW) in their 13F filings, up 1 from Q3 2025. 3 opened new positions and 2 sold out. The largest holders were Boothbay Fund Management, LLC ($130K), RTW Investments, LP ($9K) and Sio Capital Management, LLC ($7K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Rocket Pharmaceuticals in-27
- CUSIP
- 77313F114
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $403 |
| Exits | 2 | $2K |
All 13F filers, Q3 2025 → Q4 2025: 35,346 shares bought and 359,552 shares sold, net −324,206 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Boothbay Fund Management, LLC | — | No change | 36,912 | $130K |
| RTW Investments, LP | — | No change | 350,000 | $9K |
| Sio Capital Management, LLC | — | No change | 400,000 | $7K |
| Walleye Capital LLC | — | Reduce -52.1% | 284,345 | $7K |
| Citadel Advisors | — | Reduce -0.4% | 311,489 | $6K |
| Silverarc Capital Management, LLC | — | No change | 104,828 | $3K |
| LMR Partners LLP | — | No change | 75,731 | $2K |
| Affinity Asset Advisors, LLC | — | No change | 75,000 | $2K |
| Two Sigma Securities, LLC | — | New | 16,500 | $401 |
| Ancora Advisors LLC | — | No change | 6,000 | $146 |
| Clear Street Group Inc. | — | New | 100 | $2 |
| Virtu Financial LLC | — | New | 18,746 | $0 |
"% of holder's portfolio" is RCKTW's weight in each manager's 13F, not the share of Rocket Pharmaceuticals in-27 the manager owns.